Zhirong Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhirong Wang has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Cheng Guo
Endoscopy Center, Department of Gastroenterology, Shanghai East Hospital
5 shared publicationsYanli Ge
Department of Gastroenterology, Tongji Hospital, School of Medicine, Tongji University
5 shared publicationsBoyu Ma
Department of Gastroenterology, Tongji Hospital affiliated to Tongji University, School of Medicine, Tongji University, Shanghai, China
4 shared publications- Junjie Zhang
Department of Gastroenterology, Tongji Hospital, School of Medicine, Tongji University
4 shared publications - Zhe Wang
Department of Gastroenterology, Tongji Hospital, School of Medicine, Tongji University
4 shared publications Junjie Zhang
Department of Gastroenterology, Tongji Hospital affiliated to Tongji University, School of Medicine, Tongji University, Shanghai, China
3 shared publications
Latest Publications
- Open Access
- 9 November 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 2034591
CircNF1 promotes gastric cancer metastasis by stabilizing HMGA2 mRNA through IGF2BP1 interaction
- 9 November 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 2034591
Open AccessCircNF1 promotes gastric cancer metastasis by stabilizing HMGA2 mRNA through IGF2BP1 interaction
- Open Access
- 17 February 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (2) , e0342336
Interaction effects of sedentary behavior and depression on MAFLD in NHANES 2017–2020 and 2021–2023
Background: Metabolic-associated fatty liver disease (MAFLD), a disease closely associated with metabolic abnormalities (e.g., insulin resistance, dyslipidemia, elevated blood glucose, and obesity), has become a global public health challenge. This study explored the independent associations between sedentary behavior and depressive symptoms with MAFLD and analyzed the potential interactions between these two factors and the risk of MAFLD occurrence. Methods: This cross-sectional study is based on data from two cycles of the National Health and Nutrition Examination Survey (NHANES) from 2017 ~ 2020 and 2021 ~ 2023 and analyzes the relationships among depressive symptoms, sedentary behavior, potential confounding factors, and MAFLD. A multivariate logistic regression model was used in the present study, and different subgroups of sedentary behavior were analyzed to assess the associations among sedentary behavior, depression and MAFLD. In addition, the presence of additive interactions among these variables was assessed by calculating the relative excess risk due to interaction (RERI), attributable proportion due to interaction (AP), and synergy index (S). Results: A total of 10,612 participants were included in this study (weighted sample size of 183,231,593), of whom 4,501 (weighted proportion of 42%) had MAFLD. Compared with participants with less daily sedentary time, those with more sedentary time had a greater risk of MAFLD (OR = 1.33, 95% CI: 1.08 ~ 1.64). We also found that, compared with individuals without depressive symptoms, individuals with depressive symptoms were significantly associated with an increased risk of MAFLD (OR = 1.26, 95% CI: 1.03 ~ 1.54). Furthermore, sedentary behavior significantly interacted with depression in overweight individuals, affecting the risk of MAFLD (relative excess risk (RERI) = 0.684, 95% CI: 0.312 ~ 1.057; attributable proportion (AP) = 0.360, 95% CI: 0.323 ~ 0.397; synergy index (S) = 1.623, 95% CI: 1.177 ~ 2.070). Poisson regression with 90% CI confirmed this interaction (RERI = 0.318, 90% CI: 0.036 ~ 0.600; AP = 0.223, 90% CI: 0.182 ~ 0.263; S=1.310, 90% CI: 1.000 ~ 1.620). Conclusion: Sedentary behavior and depression have a significant synergistic effect on MAFLD in overweight individuals. Therefore, improving individuals’ psychological health status and reducing sedentary time may have positive effects on the prevention and treatment of MAFLD.
- 17 February 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (2) , e0342336
Open AccessInteraction effects of sedentary behavior and depression on MAFLD in NHANES 2017–2020 and 2021–2023
Background: Metabolic-associated fatty liver disease (MAFLD), a disease closely associated with metabolic abnormalities (e.g., insulin resistance, dyslipidemia, elevated blood glucose, and obesity), has become a global public health challenge. This study explored the independent associations between sedentary behavior and depressive symptoms with MAFLD and analyzed the potential interactions between these two factors and the risk of MAFLD occurrence. Methods: This cross-sectional study is based on data from two cycles of the National Health and Nutrition Examination Survey (NHANES) from 2017 ~ 2020 and 2021 ~ 2023 and analyzes the relationships among depressive symptoms, sedentary behavior, potential confounding factors, and MAFLD. A multivariate logistic regression model was used in the present study, and different subgroups of sedentary behavior were analyzed to assess the associations among sedentary behavior, depression and MAFLD. In addition, the presence of additive interactions among these variables was assessed by calculating the relative excess risk due to interaction (RERI), attributable proportion due to interaction (AP), and synergy index (S). Results: A total of 10,612 participants were included in this study (weighted sample size of 183,231,593), of whom 4,501 (weighted proportion of 42%) had MAFLD. Compared with participants with less daily sedentary time, those with more sedentary time had a greater risk of MAFLD (OR = 1.33, 95% CI: 1.08 ~ 1.64). We also found that, compared with individuals without depressive symptoms, individuals with depressive symptoms were significantly associated with an increased risk of MAFLD (OR = 1.26, 95% CI: 1.03 ~ 1.54). Furthermore, sedentary behavior significantly interacted with depression in overweight individuals, affecting the risk of MAFLD (relative excess risk (RERI) = 0.684, 95% CI: 0.312 ~ 1.057; attributable proportion (AP) = 0.360, 95% CI: 0.323 ~ 0.397; synergy index (S) = 1.623, 95% CI: 1.177 ~ 2.070). Poisson regression with 90% CI confirmed this interaction (RERI = 0.318, 90% CI: 0.036 ~ 0.600; AP = 0.223, 90% CI: 0.182 ~ 0.263; S=1.310, 90% CI: 1.000 ~ 1.620). Conclusion: Sedentary behavior and depression have a significant synergistic effect on MAFLD in overweight individuals. Therefore, improving individuals’ psychological health status and reducing sedentary time may have positive effects on the prevention and treatment of MAFLD.
- Open Access
- 17 February 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1767319
CircNF1 promotes gastric cancer metastasis by stabilizing HMGA2 mRNA through IGF2BP1 interaction
Introduction: Gastric cancer (GC) is the fifth most common malignancy worldwide, with metastasis being the primary cause of mortality. Although circular RNAs (circRNAs) are implicated in GC pathogenesis, their specific roles in metastasis remain unclear. This study was designed to investigate the functional significance and underlying molecular mechanisms of circNF1 in GC metastasis. Methods: The expression of circNF1 was assessed in GC tissues and paired adjacent normal tissues using in situ hybridization, and its clinical relevance was evaluated via Cox regression analysis. Functional characterization was performed using transwell migration assays and in vivo metastatic mouse models to determine the effects of circNF1 overexpression or knockdown on GC cell motility and lung metastasis. Mechanistic investigations included molecular interaction studies to explore the association between circNF1 and IGF2BP1, as well as transcriptional regulation assays to identify the upstream regulator of circNF1 biogenesis. Results: Overexpression of circNF1 significantly enhanced GC cell migration in vitro and lung metastasis in vivo, whereas knockdown of circNF1 suppressed these metastatic phenotypes. Mechanistically, circNF1 was found to interact directly with IGF2BP1, thereby stabilizing HMGA2 mRNA and promoting its expression. Furthermore, ZNF460 was identified as a transcriptional activator of the NF1 host gene, which in turn upregulated circNF1 expression. Discussion: Our findings demonstrate that ZNF460-mediated upregulation of circNF1 drives GC metastasis by acting as a molecular scaffold to interact with IGF2BP1 and stabilize HMGA2 mRNA. This study not only elucidates a novel regulatory axis in GC metastasis but also identifies circNF1 as a promising prognostic biomarker and potential therapeutic target for the treatment of metastatic GC.
- 17 February 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1767319
Open AccessCircNF1 promotes gastric cancer metastasis by stabilizing HMGA2 mRNA through IGF2BP1 interaction
Introduction: Gastric cancer (GC) is the fifth most common malignancy worldwide, with metastasis being the primary cause of mortality. Although circular RNAs (circRNAs) are implicated in GC pathogenesis, their specific roles in metastasis remain unclear. This study was designed to investigate the functional significance and underlying molecular mechanisms of circNF1 in GC metastasis. Methods: The expression of circNF1 was assessed in GC tissues and paired adjacent normal tissues using in situ hybridization, and its clinical relevance was evaluated via Cox regression analysis. Functional characterization was performed using transwell migration assays and in vivo metastatic mouse models to determine the effects of circNF1 overexpression or knockdown on GC cell motility and lung metastasis. Mechanistic investigations included molecular interaction studies to explore the association between circNF1 and IGF2BP1, as well as transcriptional regulation assays to identify the upstream regulator of circNF1 biogenesis. Results: Overexpression of circNF1 significantly enhanced GC cell migration in vitro and lung metastasis in vivo, whereas knockdown of circNF1 suppressed these metastatic phenotypes. Mechanistically, circNF1 was found to interact directly with IGF2BP1, thereby stabilizing HMGA2 mRNA and promoting its expression. Furthermore, ZNF460 was identified as a transcriptional activator of the NF1 host gene, which in turn upregulated circNF1 expression. Discussion: Our findings demonstrate that ZNF460-mediated upregulation of circNF1 drives GC metastasis by acting as a molecular scaffold to interact with IGF2BP1 and stabilize HMGA2 mRNA. This study not only elucidates a novel regulatory axis in GC metastasis but also identifies circNF1 as a promising prognostic biomarker and potential therapeutic target for the treatment of metastatic GC.
- Open Access
- 16 December 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-22
Selectively targeting the AdipoR2-CaM-CaMKII-NOS3 axis by SCM-198 as a rapid-acting therapy for advanced acute liver failure
Acute liver failure (ALF) is a hepatology emergency with rapid hepatic destruction, multiple organ failures, and high mortality. Despite decades of research, established ALF has minimal therapeutic options. Here, we report that the small bioactive compound SCM-198 increases the survival of male ALF mice to 100%, even administered 24 hours after ALF establishment. We identify adiponectin receptor 2 (AdipoR2) as a selective target of SCM-198, with the AdipoR2 R335 residue being critical for the binding and signaling of SCM-198-AdipoR2 and AdipoR2 Y274 residue serving as a molecular switch for Ca2+ influx. SCM-198-AdipoR2 binding causes Ca2+ influx and elevates the phosphorylation levels of CaMKII and NOS3 in the AdipoR2-CaM-CaMKII-NOS3 complex identified in this study, rapidly inducing nitric oxide production for liver protection in murine ALF. SCM-198 also protects human ESC-derived liver organoids from APAP/TAA injuries. Thus, selectively targeting the AdipoR2-CaM-CaMKII-NOS3 axis by SCM-198 is a rapid-acting therapeutic strategy for advanced ALF.
- 16 December 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-22
Open AccessSelectively targeting the AdipoR2-CaM-CaMKII-NOS3 axis by SCM-198 as a rapid-acting therapy for advanced acute liver failure
Acute liver failure (ALF) is a hepatology emergency with rapid hepatic destruction, multiple organ failures, and high mortality. Despite decades of research, established ALF has minimal therapeutic options. Here, we report that the small bioactive compound SCM-198 increases the survival of male ALF mice to 100%, even administered 24 hours after ALF establishment. We identify adiponectin receptor 2 (AdipoR2) as a selective target of SCM-198, with the AdipoR2 R335 residue being critical for the binding and signaling of SCM-198-AdipoR2 and AdipoR2 Y274 residue serving as a molecular switch for Ca2+ influx. SCM-198-AdipoR2 binding causes Ca2+ influx and elevates the phosphorylation levels of CaMKII and NOS3 in the AdipoR2-CaM-CaMKII-NOS3 complex identified in this study, rapidly inducing nitric oxide production for liver protection in murine ALF. SCM-198 also protects human ESC-derived liver organoids from APAP/TAA injuries. Thus, selectively targeting the AdipoR2-CaM-CaMKII-NOS3 axis by SCM-198 is a rapid-acting therapeutic strategy for advanced ALF.
- 16 March 2024
- Published by Elsevier in Experimental Cell Research
- Vol. 437 (1) , 113992
Notoginsenoside R1 targets PPAR-γ to inhibit hepatic stellate cell activation and ameliorates liver fibrosis
- 16 March 2024
- Published by Elsevier in Experimental Cell Research
- Vol. 437 (1) , 113992
Notoginsenoside R1 targets PPAR-γ to inhibit hepatic stellate cell activation and ameliorates liver fibrosis
- Open Access
- 28 July 2023
- Published by Wolters Kluwer Health in Journal of the Chinese Medical Association
- Vol. 86 (9) , 806-817
POFUT1 promotes gastric cancer progression through Notch/Wnt dual signaling pathways dependent on the parafibromin-NICD1-β-catenin complex
Background: Aberrant glycosylation performed by glycosyltransferases is a leading cause of gastric cancer (GC). Protein O-fucosyltransferase 1 (POFUT1) expression is increased in GC specimens and cells. In this study, the biological effects and mechanisms of POFUT1 underlying the development of GC were investigated. Methods: POFUT1 downregulated and upregulated GC cells were established. The effects of POFUT1 on cell proliferation, metastasis and apoptosis were examined using CCK8 assay, transwell assay, and flow cytometry. Subcutaneous xenograft tumor models were established followed by immunohistochemistry staining of resected tumors. Facilitating modulators and transcription factors were detected by western blot, immunofluorescence, luciferase reporter assay, and co-immunoprecipitation. Results: POFUT1 played a pro-oncogenic role both in vivo and in vitro, which promoted proliferation and metastasis, as well as inhibited apoptosis in GC cells. POFUT1 promoted Cyclin D3 expression and inhibited the expression of apoptotic proteins, such as Bax and cleaved caspase 3, facilitating tumor growth. Moreover, POFUT1 accelerated matrix metalloproteases expression and attenuated E-cadherin expression, contributing to GC metastasis. In addition, POFUT1 expression promoted the expression and nuclear translocation of Notch1 intracellular domain (NICD1) and β-catenin and inhibited β-catenin phosphorylation degradation, accompanied by the activation of recombination signal binding protein-Jκ (RBP-J) and T-cell factor (TCF) transcription factors respectively. It is notable that parafibromin integrated NICD1 and β-catenin, enabling the concerted activation of Wnt and Notch signaling targeted proteins. Conclusion: These observations indicated that POFUT1 promoted GC development through activation of Notch and Wnt signaling pathways, which depended on the parafibromin-NICD1-β-catenin complex. This work provides new evidence for the further diagnosis and treatment of GC.
- 28 July 2023
- Published by Wolters Kluwer Health in Journal of the Chinese Medical Association
- Vol. 86 (9) , 806-817
Open AccessPOFUT1 promotes gastric cancer progression through Notch/Wnt dual signaling pathways dependent on the parafibromin-NICD1-β-catenin complex
Background: Aberrant glycosylation performed by glycosyltransferases is a leading cause of gastric cancer (GC). Protein O-fucosyltransferase 1 (POFUT1) expression is increased in GC specimens and cells. In this study, the biological effects and mechanisms of POFUT1 underlying the development of GC were investigated. Methods: POFUT1 downregulated and upregulated GC cells were established. The effects of POFUT1 on cell proliferation, metastasis and apoptosis were examined using CCK8 assay, transwell assay, and flow cytometry. Subcutaneous xenograft tumor models were established followed by immunohistochemistry staining of resected tumors. Facilitating modulators and transcription factors were detected by western blot, immunofluorescence, luciferase reporter assay, and co-immunoprecipitation. Results: POFUT1 played a pro-oncogenic role both in vivo and in vitro, which promoted proliferation and metastasis, as well as inhibited apoptosis in GC cells. POFUT1 promoted Cyclin D3 expression and inhibited the expression of apoptotic proteins, such as Bax and cleaved caspase 3, facilitating tumor growth. Moreover, POFUT1 accelerated matrix metalloproteases expression and attenuated E-cadherin expression, contributing to GC metastasis. In addition, POFUT1 expression promoted the expression and nuclear translocation of Notch1 intracellular domain (NICD1) and β-catenin and inhibited β-catenin phosphorylation degradation, accompanied by the activation of recombination signal binding protein-Jκ (RBP-J) and T-cell factor (TCF) transcription factors respectively. It is notable that parafibromin integrated NICD1 and β-catenin, enabling the concerted activation of Wnt and Notch signaling targeted proteins. Conclusion: These observations indicated that POFUT1 promoted GC development through activation of Notch and Wnt signaling pathways, which depended on the parafibromin-NICD1-β-catenin complex. This work provides new evidence for the further diagnosis and treatment of GC.
- Open Access
- 24 August 2021
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 8
A Somatic Mutation-Derived LncRNA Signature of Genomic Instability Predicts Prognosis for Patients With Liver Cancer
Background: Genomic instability is considered as one of the hallmarks of hepatocellular carcinoma (HCC) and poses a significant challenge to the clinical treatment. The emerging evidence has revealed the roles of long non-coding RNAs (lncRNAs) in the maintenance of genomic instability. This study is aimed to develop a genomic instability-related lncRNA signature for determining HCC prognosis and the suitability of patients for immunotherapy.Methods: In this study, data related to transcriptome profiling, clinical features, and the somatic mutations of patients with HCC were downloaded from The Cancer Genomic Atlas (TCGA). Bioinformatics analysis was performed to identify and construct a somatic mutation-derived genomic instability-associated lncRNA signature (GILncSig). Single-sample gene set enrichment analysis (ssGSEA) was applied to estimate the levels of immune cell infiltration. A nomogram was constructed, and calibration was performed to assess the effectiveness of the model.Results: In the study, seven genomic instability-related lncRNAs were identified and used to define a prognostic signature. Patients with HCC were stratified into high- and low-risk groups with significant differences in the survival (median survival time = 1.489, 1.748 year; p = 0.006) based on the optimal cutoff value (risk score = 1.010) of the risk score in the training group. In addition, GILncSig was demonstrated to be an independent risk factor for the patients with HCC when compared to the clinical parameters (p < 0.001). According to the receiver operating characteristic (ROC) curve, nomogram, and calibration plot, the signature could predict the survival rate for the patients with HCC in the 1st, 3rd, and 5th years. Furthermore, ssGSEA revealed the potential of the signature in guiding decisions for administering clinical treatment.Conclusions: In this study, we developed a novel prognostic model based on the somatic mutation-derived lncRNAs and validated it using an internal dataset. The independence of the GILncSig was estimated using univariate and follow-up multivariate analyses. Immunologic analysis was used to evaluate the complex factors involved in the HCC progression.
- 24 August 2021
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 8
Open AccessA Somatic Mutation-Derived LncRNA Signature of Genomic Instability Predicts Prognosis for Patients With Liver Cancer
Background: Genomic instability is considered as one of the hallmarks of hepatocellular carcinoma (HCC) and poses a significant challenge to the clinical treatment. The emerging evidence has revealed the roles of long non-coding RNAs (lncRNAs) in the maintenance of genomic instability. This study is aimed to develop a genomic instability-related lncRNA signature for determining HCC prognosis and the suitability of patients for immunotherapy.Methods: In this study, data related to transcriptome profiling, clinical features, and the somatic mutations of patients with HCC were downloaded from The Cancer Genomic Atlas (TCGA). Bioinformatics analysis was performed to identify and construct a somatic mutation-derived genomic instability-associated lncRNA signature (GILncSig). Single-sample gene set enrichment analysis (ssGSEA) was applied to estimate the levels of immune cell infiltration. A nomogram was constructed, and calibration was performed to assess the effectiveness of the model.Results: In the study, seven genomic instability-related lncRNAs were identified and used to define a prognostic signature. Patients with HCC were stratified into high- and low-risk groups with significant differences in the survival (median survival time = 1.489, 1.748 year; p = 0.006) based on the optimal cutoff value (risk score = 1.010) of the risk score in the training group. In addition, GILncSig was demonstrated to be an independent risk factor for the patients with HCC when compared to the clinical parameters (p < 0.001). According to the receiver operating characteristic (ROC) curve, nomogram, and calibration plot, the signature could predict the survival rate for the patients with HCC in the 1st, 3rd, and 5th years. Furthermore, ssGSEA revealed the potential of the signature in guiding decisions for administering clinical treatment.Conclusions: In this study, we developed a novel prognostic model based on the somatic mutation-derived lncRNAs and validated it using an internal dataset. The independence of the GILncSig was estimated using univariate and follow-up multivariate analyses. Immunologic analysis was used to evaluate the complex factors involved in the HCC progression.
- Open Access
- 19 July 2021
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 8
An Immune Signature Robustly Predicts Clinical Deterioration for Hepatitis C Virus-Related Early-Stage Cirrhosis Patients
Hepatitis C virus (HCV)-related cirrhosis leads to a heavy global burden of disease. Clinical risk stratification in HCV-related compensated cirrhosis remains a major challenge. Here, we aim to develop a signature comprised of immune-related genes to identify patients at high risk of progression and systematically analyze immune infiltration in HCV-related early-stage cirrhosis patients. Bioinformatics analysis was applied to identify immune-related genes and construct a prognostic signature in microarray data set. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) functional enrichment analyses were conducted with the “clusterProfiler” R package. Besides, the single sample gene set enrichment analysis (ssGSEA) was used to quantify immune-related risk term abundance. The nomogram and calibrate were set up via the integration of the risk score and clinicopathological characteristics to assess the effectiveness of the prognostic signature. Finally, three genes were identified and were adopted to build an immune-related prognostic signature for HCV-related cirrhosis patients. The signature was proved to be an independent risk element for HCV-related cirrhosis patients. In addition, according to the time-dependent receiver operating characteristic (ROC) curves, nomogram, and calibration plot, the prognostic model could precisely forecast the survival rate at the first, fifth, and tenth year. Notably, functional enrichment analyses indicated that cytokine activity, chemokine activity, leukocyte migration and chemotaxis, chemokine signaling pathway and viral protein interaction with cytokine and cytokine receptor were involved in HCV-related cirrhosis progression. Moreover, ssGSEA analyses revealed fierce immune-inflammatory response mechanisms in HCV progress. Generally, our work developed a robust prognostic signature that can accurately predict the overall survival, Child-Pugh class progression, hepatic decompensation, and hepatocellular carcinoma (HCC) for HCV-related early-stage cirrhosis patients. Functional enrichment and further immune infiltration analyses systematically elucidated potential immune response mechanisms.
- 19 July 2021
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 8
Open AccessAn Immune Signature Robustly Predicts Clinical Deterioration for Hepatitis C Virus-Related Early-Stage Cirrhosis Patients
Hepatitis C virus (HCV)-related cirrhosis leads to a heavy global burden of disease. Clinical risk stratification in HCV-related compensated cirrhosis remains a major challenge. Here, we aim to develop a signature comprised of immune-related genes to identify patients at high risk of progression and systematically analyze immune infiltration in HCV-related early-stage cirrhosis patients. Bioinformatics analysis was applied to identify immune-related genes and construct a prognostic signature in microarray data set. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) functional enrichment analyses were conducted with the “clusterProfiler” R package. Besides, the single sample gene set enrichment analysis (ssGSEA) was used to quantify immune-related risk term abundance. The nomogram and calibrate were set up via the integration of the risk score and clinicopathological characteristics to assess the effectiveness of the prognostic signature. Finally, three genes were identified and were adopted to build an immune-related prognostic signature for HCV-related cirrhosis patients. The signature was proved to be an independent risk element for HCV-related cirrhosis patients. In addition, according to the time-dependent receiver operating characteristic (ROC) curves, nomogram, and calibration plot, the prognostic model could precisely forecast the survival rate at the first, fifth, and tenth year. Notably, functional enrichment analyses indicated that cytokine activity, chemokine activity, leukocyte migration and chemotaxis, chemokine signaling pathway and viral protein interaction with cytokine and cytokine receptor were involved in HCV-related cirrhosis progression. Moreover, ssGSEA analyses revealed fierce immune-inflammatory response mechanisms in HCV progress. Generally, our work developed a robust prognostic signature that can accurately predict the overall survival, Child-Pugh class progression, hepatic decompensation, and hepatocellular carcinoma (HCC) for HCV-related early-stage cirrhosis patients. Functional enrichment and further immune infiltration analyses systematically elucidated potential immune response mechanisms.
- 1 April 2020
- Vol. 24 (7) , 3633-3641
Potential effects of IL-17A rs2275913 and IL-17F rs763780 polymorphisms on susceptibility to gastric cancer in Chinese population: a meta-analysis
OBJECTIVE: This meta-analysis aims to clarify the effect of IL-17 polymorphisms on the susceptibility to GCa in the Chinese population. MATERIALS AND METHODS: Relevant pieces of literature were searched in PubMed, Web of School, VIP, and CNKI using the key words as "IL-17, gastric/stomach cancer" or "IL-17 polymorphisms, gastric/stomach cancer susceptibility". The odds ratio (OR) and 95% confidence interval (Cl) in the selected studies were calculated using RevMan5.3 and STATA12.0. RESULTS: A total of 12 investigations reporting mutations in IL-17A rs2275913 and IL-17F rs763780 were enrolled. There were 11 studies reporting rs2275913 G>A, involving 3299 cases of GCa patients and 3339 cases of healthy controls. The random-effects model was performed since the heterogeneity test results of the recessive genetic model (GG&GA vs. AA) and the allelic model (G vs. A) of IL-17A rs2275913 G>A were12>66%Ip=0.001. Meanwhile, the dominant genetic model (GG vs. GA&AA) and the super-dominant genetic model (GA vs. GG&AA) of 1L-17A rs2275913 G>A were 12< 50%/p>0.05, and the fixed-effects model was used. The meta-analysis showed that 1L-17A rs2275913 G>A was positively correlated with GCa susceptibility under four genetic models (pC were enrolled, including 2535 cases of GCa patients and 2402 cases of healthy controls. The heterogeneity test showed that, except for the super-dominant genetic model, the p-value was C was positively correlated with GCa susceptibility under the super-dominant genetic model (p=0.003), rather than the other three models (p>0.05). CONCLUSIONS: 1L-17A rs2275913 G>A polymorphism contributes to susceptibility to GCa in the dominant, recessive, allelic, and super-dominant models. Meanwhile. IL-17F rs763780 T>C polymorphism is positively correlated with GCa susceptibility in the super-dominant model.
- 1 April 2020
- Vol. 24 (7) , 3633-3641
Potential effects of IL-17A rs2275913 and IL-17F rs763780 polymorphisms on susceptibility to gastric cancer in Chinese population: a meta-analysis
OBJECTIVE: This meta-analysis aims to clarify the effect of IL-17 polymorphisms on the susceptibility to GCa in the Chinese population. MATERIALS AND METHODS: Relevant pieces of literature were searched in PubMed, Web of School, VIP, and CNKI using the key words as "IL-17, gastric/stomach cancer" or "IL-17 polymorphisms, gastric/stomach cancer susceptibility". The odds ratio (OR) and 95% confidence interval (Cl) in the selected studies were calculated using RevMan5.3 and STATA12.0. RESULTS: A total of 12 investigations reporting mutations in IL-17A rs2275913 and IL-17F rs763780 were enrolled. There were 11 studies reporting rs2275913 G>A, involving 3299 cases of GCa patients and 3339 cases of healthy controls. The random-effects model was performed since the heterogeneity test results of the recessive genetic model (GG&GA vs. AA) and the allelic model (G vs. A) of IL-17A rs2275913 G>A were12>66%Ip=0.001. Meanwhile, the dominant genetic model (GG vs. GA&AA) and the super-dominant genetic model (GA vs. GG&AA) of 1L-17A rs2275913 G>A were 12< 50%/p>0.05, and the fixed-effects model was used. The meta-analysis showed that 1L-17A rs2275913 G>A was positively correlated with GCa susceptibility under four genetic models (pC were enrolled, including 2535 cases of GCa patients and 2402 cases of healthy controls. The heterogeneity test showed that, except for the super-dominant genetic model, the p-value was C was positively correlated with GCa susceptibility under the super-dominant genetic model (p=0.003), rather than the other three models (p>0.05). CONCLUSIONS: 1L-17A rs2275913 G>A polymorphism contributes to susceptibility to GCa in the dominant, recessive, allelic, and super-dominant models. Meanwhile. IL-17F rs763780 T>C polymorphism is positively correlated with GCa susceptibility in the super-dominant model.
- 1 January 2017
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 483 (1) , 171-177
Bioinformatics insight into glycosyltransferase gene expression in gastric cancer: POFUT1 is a potential biomarker
- 1 January 2017
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 483 (1) , 171-177
Bioinformatics insight into glycosyltransferase gene expression in gastric cancer: POFUT1 is a potential biomarker